$58.50
Price
$9.2B
Market Cap
110.4
P/E Ratio
26.9
Forward P/E
$0.53
EPS (TTM)
0.55%
Dividend Yield
$180M
Cash
$444M
Total Debt
156M
Shares Out
$46.01
$72.16
52-Week Range
Institutional Ownership of BIO TECHNE CORP
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Sequoia Fund|Ruane Cunniff
|
1.5M | $86M | $52.87 | +31.75% |
Trading Activity for BIO TECHNE CORP
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q4 | |||||
| SELL | -0.5% | 1.5M | $86M | $60.29 | |
| 2025-Q3 | |||||
| BUY | +3.4% | 2.8M | $156M | $53.21 | |
| BUY | +866.9% | 1.5M | $82M | $53.21 | |
| SELL | EXIT | — | — | $53.21 | |
| 2025-Q2 | |||||
| BUY | +2.4% | 2.7M | $140M | $49.89 | |
| BUY | NEW | 152.4K | $8M | $49.89 | |
| SELL | EXIT | — | — | $49.89 | |
| 2025-Q1 | |||||
| SELL | -0.8% | 2.7M | $155M | $65.94 | |
| SELL | -13.3% | 47.5K | $3M | $65.94 | |
| BUY | +68.8% | 46.3K | $3M | $65.94 | |
| 2024-Q4 | |||||
| SELL | -0.8% | 2.7M | $193M | $73.82 | |
| 2024-Q3 | |||||
| SELL | -1.6% | 2.7M | $216M | $74.67 | |
| BUY | +5.2% | 54.8K | $4M | $74.67 | |
| SELL | -22.6% | 27.4K | $2M | $74.67 | |
| 2024-Q2 | |||||
| SELL | -7.4% | 2.7M | $196M | $74.81 | |
| BUY | +58.4% | 35.5K | $3M | $74.81 | |
| 2024-Q1 | |||||
| SELL | -3.9% | 3.0M | $208M | $71.76 | |
| 2023-Q4 | |||||
| BUY | +0.8% | 3.1M | $238M | $64.57 | |
| BUY | +23.9% | 52.1K | $4M | $64.57 | |
| BUY | NEW | 22.4K | $2M | $64.57 | |
| 2023-Q3 | |||||
| SELL | -0.2% | 3.1M | $208M | $80.80 | |
| SELL | -3.3% | 42.0K | $3M | $80.80 | |
| 2023-Q2 | |||||
| BUY | +1.1% | 3.1M | $250M | $81.22 | |
| BUY | +16.5% | 43.4K | $4M | $81.22 | |
| 2023-Q1 | |||||
| BUY | +7.7% | 3.0M | $224M | $76.80 | |
| BUY | NEW | 37.3K | $3M | $76.80 | |
| 2022-Q4 | |||||
| BUY | +317.3% | 2.8M | $233M | $80.73 | |
| 2022-Q3 | |||||
| BUY | +2.7% | 673.6K | $191M | $87.56 | |
| 2022-Q2 | |||||
| SELL | -0.3% | 655.9K | $227M | $91.61 | |
| 2022-Q1 | |||||
| BUY | +0.6% | 658.0K | $285M | $103.77 | |
| 2021-Q4 | |||||
| SELL | -1.3% | 653.8K | $338M | $123.48 | |
| 2021-Q3 | |||||
| SELL | -9.1% | 662.6K | $321M | $120.45 | |
| 2021-Q2 | |||||
| SELL | -5.3% | 728.8K | $328M | $104.75 | |
| 2021-Q1 | |||||
| SELL | -9.2% | 770.0K | $294M | $92.23 | |
| 2020-Q4 | |||||
| SELL | -0.8% | 848.1K | $269M | $75.44 | |
| 2020-Q3 | |||||
| SELL | -5.2% | 855.4K | $212M | $65.45 | |
| 2020-Q2 | |||||
| SELL | -11.9% | 902.0K | $238M | $63.46 | |
| 2020-Q1 | |||||
| BUY | +2.1% | 1.0M | $194M | $51.41 | |
| 2019-Q4 | |||||
| SELL | -3.6% | 1.0M | $220M | $52.56 | |
| 2019-Q3 | |||||
| SELL | -2.6% | 1.0M | $204M | $49.98 | |
| 2019-Q2 | |||||
| SELL | -7.4% | 1.1M | $223M | $50.38 | |
| 2019-Q1 | |||||
| SELL | -3.1% | 1.2M | $229M | $47.26 | |
| 2018-Q4 | |||||
| BUY | +1.7% | 1.2M | $172M | $40.98 | |
| 2018-Q3 | |||||
| SELL | -9.3% | 1.2M | $239M | $45.03 | |
| 2018-Q2 | |||||
| SELL | -6.3% | 1.3M | $191M | $37.90 | |
| 2018-Q1 | |||||
| SELL | -3.9% | 1.4M | $208M | $35.27 | |
Insider Trading for BIO TECHNE CORP
6 Months Insider Sentiment
Buy $0
Sell $0
0
Buys
0
Sells
+0
Net
8
Grants
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Nov 03, 2025 | James Hippel | CFO | EXERCISE | 11.5K | — | — |
| Nov 03, 2025 | James Hippel | CFO | EXERCISE | 13.2K | — | — |
| Nov 03, 2025 | William Geist | PRESIDENT, PROTEIN SCIENCES | EXERCISE | 9.9K | — | — |
| Oct 30, 2025 | Alpna Seth | Director | GRANT | 1.6K | — | — |
| Oct 30, 2025 | Judith V. Klimovsky | Director | GRANT | 1.6K | — | — |
| Oct 30, 2025 | Julie L Bushman | Director | GRANT | 1.6K | — | — |
| Oct 30, 2025 | Robert V Baumgartner | Director | GRANT | 1.6K | — | — |
| Oct 30, 2025 | Rupert Vessey | Director | GRANT | 1.6K | — | — |
| Oct 30, 2025 | Joseph D Keegan | Director | GRANT | 1.6K | — | — |
| Oct 30, 2025 | Amy E. Herr | Director | GRANT | 1.6K | — | — |
| Oct 30, 2025 | John L Higgins | Director | GRANT | 1.6K | — | — |